Skip to main content

Table 2 Multivariable Survival Analysis

From: Post-therapy pathologic tumor volume predicts survival in gastric cancer patients who underwent neoadjuvant chemotherapy and gastrectomy

Parameters

B

SE

HR

Hazard ratio

(95% CI)

P

Tumor volume (ypTV)

 ypTV1

 ypTV2

0.10

0.30

1.08

1.01–1.61

0.045

 ypTV3

0.43

0.21

1.53

1.02–2.31

0.042

 ypTV4a

0.69

0.32

1.99

1.06–3.72

0.032

 ypTV4b

0.89

0.30

2.44

1.35–4.41

0.003

ypN stage

 N0

 N1

0.63

0.27

1.88

1.11–3.2

0.019

 N2

0.65

0.22

1.92

1.25–2.93

0.003

 N3

0.70

0.27

2.01

1.18–3.42

0.010

ypTvNM stage

 I

  

1.00

  

 II

0.22

0.07

1.25

1.09–1.43

0.001

 III

0.64

0.23

1.90

1.22–2.96

0.005

Response to neoadjuvant chemotherapy

 PR

 SD

0.44

0.23

1.65

1.08–2.43

0.041

 PD

0.61

0.23

1.85

1.17–2.92

0.009

Vascular invasion

 No

 Yes

0.45

0.22

1.58

1.03–2.4

0.035